AMIGOs

Australasian Merkel Cell Carcinoma Interest Group

Enabling access to high quality care for all patients with Merkel Cell Carcinoma

What is Merkel Cell Carcinoma?

Merkel Cell Carcinoma is a rare but highly aggressive neuroendocrine skin cancer

Merkel Cell Carcinoma has the potential to be lethal and appropriate management should be sought immediately through a specialist centre.

Treatment of Merkel Cell Carcinoma often involves several types of therapy such as surgery, radiation, and sometimes systemic medications. Multidisciplinary evaluation of patients with this cancer is critical to determine and carry out a proper treatment plan.

“Many patients and primary care doctors don’t understand the severity of a Merkel Cell Carcinoma diagnosis. Carers and families often don’t appreciate the seriousness of the condition. How could a skin cancer that you have never heard of, give you a deadly problem, unless it is malignant melanoma? Merkel Cell Carcinoma patients need quick referral to specialists at centres of excellence who understand this disease.”

Jonathan Pincus
Chair, Patient Advocacy Group

Jonathan Pincus

Newsfeed

On #WorldCancerDay, we join those calling to #CloseTheCareGap. We continue to open trial sites in regional towns to provide equitable access to breakthroughs in cancer treatment. We work to conquer #melanoma & #skincancer for everyone, no matter who you are or where you live.

International keynote speaker Prof @HaraldKittler from Dept of Dermatology, Medical University of Vienna, on 'Clinical trials on AI-assisted diagnosis of melanoma' at MASC Trials Annual Scientific Meeting, 23 March, Brisbane. Register: https://www.masc.org.au/asm-2023/
@MedUni_Wien

Tebentafusp (Kimmtrak) for treating advanced uveal melanoma is being assessed for possible inclusion in the PBS. MASC Trials is collating a submission supporting Tebentafusp’s inclusion, and you can contribute by completing our online survey by 22 Jan: https://forms.gle/TpzoTTqtreHZiczG8

Multicenter Merkel Interest Group (MMIG) meeting, 5 – 7pm (CST), 17 March 2023 in New Orleans, USA. More speakers wanted! Details: https://merkelcell.org/about-us/mmig/
#Merkel #MerkelCellCarcinoma #SkinCancer #MMIG

Load More...
Merkel cell carcinoma
Mailing address:

AMIGOs
C/O Melanoma and Skin Cancer Trials
553 St Kilda Road
Melbourne, VIC 3004, Australia

General enquiries:

Email: amigos@masc.org.au

Melanoma and Skin Cancer Trials
Mailing address:

Melanoma and Skin Cancer Trials
553 St Kilda Road
Melbourne, VIC 3004, Australia

General enquiries:

Email: hello@masc.org.au